Premium
Toxicity evaluation of a commercial bioremediation agent mixed with crude oil
Author(s) -
Bidwell Joseph R.,
Cherry Donald S.,
Merski A. Thomas
Publication year - 2003
Publication title -
environmental toxicology and chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.1
H-Index - 171
eISSN - 1552-8618
pISSN - 0730-7268
DOI - 10.1002/etc.5620220111
Subject(s) - bioremediation , toxicity , acute toxicity , bioassay , environmental chemistry , environmental science , crude oil , toxicology , chemistry , biology , contamination , ecology , petroleum engineering , organic chemistry , engineering
Abstract The toxicity and efficacy of a bacteria‐based commercial bioremediation agent (CBA) was assessed through bioassays with juvenile inland silverside minnows, Menidia beryllina , and flask studies of oil degradation. Addition of the CBA to weathered Alaska, USA North Slope crude oil (ANS‐521) prior to testing increased toxicity of the water‐soluble fraction (WSF) of the oil in both chronic (growth) and acute (mortality) toxicity tests. Time‐course toxicity assessment of the water‐soluble fraction of the CBA/oil combination indicated increases in effect after 7 to 14 d of mixing that coincided with elevated concentrations of both alkanes and aromatics in the WSF. Under controlled laboratory conditions, the CBA significantly enhanced degradation of the oil compared with a treatment with nutrients alone. The alkane fraction was degraded by nearly 100% over a 42‐d period while the aromatic fraction was decreased by 70%. While toxicity testing is not currently required to list bioremediation agents on the product schedule of the National Oil and Hazardous Substances Pollution Contingency Plan, the potential interaction between bioremediation agents and oil should be further investigated and listing requirements reassessed as necessary. Recommendations for future investigations of this issue include characterization of temporal trends in toxicity of CBA and oil mixtures, use of multiple test methods (battery testing) when evaluating toxicity, comparative evaluations of indigenous versus product‐derived microorganisms in efficacy studies, and the use of a comparable oil between studies to facilitate comparison of efficacy and toxicity data for different products.